IVF financial statements and SEC filings
IVF annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $6.84M | -$7.24M | -$25.13M | 10-K |
| 2024-12-31 | $6.53M | -$6.63M | -$9.51M | 10-K |
| 2023-12-31 | $3.02M | -$6.77M | -$8.03M | 10-K |
| 2022-12-31 | $822.20K | -$10.63M | -$10.89M | 10-K/A |
| 2021-12-31 | $4.16M | -$5.22M | -$6.65M | 10-K |
| 2020-12-31 | $1.04M | -$5.51M | -$8.35M | 10-K |
IVF annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $20.22M | $13.00M | $7.22M | 10-Q |
| 2024-12-31 | $46.08M | $26.04M | $12.58M | 10-K |
| 2023-12-31 | $18.51M | $17.61M | $892.83K | 10-K |
| 2022-12-31 | $3.71M | $4.69M | -$977.61K | 10-K/A |
| 2021-12-31 | $10.47M | $3.16M | $7.31M | 10-K |
| 2020-12-31 | $10.95M | $5.20M | $5.74M | 10-K |
IVF annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | -$7.01M | -$43.41K | $11.10M | 10-K |
| 2024-12-31 | -$2.97M | -$183.70K | $3.12M | 10-K |
| 2023-12-31 | -$4.76M | -$444.72K | $7.39M | 10-K |
| 2022-12-31 | -$6.60M | -$10.79K | $1.09M | 10-K/A |
| 2021-12-31 | -$6.03M | -$415.71K | $3.77M | 10-K |
| 2020-12-31 | -$4.78M | -$49.26K | $13.82M | 10-K |